Biglycan peptide and antibodies

SE548329C2Active Publication Date: 2026-06-08SGPTH LIFE SCI AB

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: SE2150815
Authority / Receiving Office: SE · SE
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2021-06-23
Publication Date: 2026-06-08
Estimated Expiration: 2041-06-23

Application Information

Patent Timeline

23 Jun 2021

Application

SE2150815

08 Jun 2026

Publication

SE548329C2

CPC: G01N33/6887; C07K14/78; G01N2333/78; G01N2800/10; G01N2333/4722; G01N2800/108; C07K2317/34; C07K16/18

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

There is provided an antibody that specifically binds to a peptide comprising the amino acid sequence N-terminal- GLGHN (SEQ ID NO 1), where the antibody binds to the sequence N-terminal-GLGHN (SEQ ID NO 1). The antibody can be used for diagnosis of for example osteoarthritis.

Need to check novelty before this filing date? Find Prior Art